2025

Blood Test Identifies HPV-Associated Head and Neck Cancers Up to 10 Years Before Symptoms

New Blood Test for HPV+ Head and Neck Cancer Tops Existing Tests, Tissue Biopsy

Mass General Brigham Liquid Biopsy Test Shows Ability to Detect HPV-Linked Head, Neck Cancer Early

New Blood Test Developed at Mass General Brigham Shows Superior Sensitivity in Detecting HPV-Associated Head and Neck Cancers

2024

Breaking Ground: ctHPVDNA Blood Test for HPV+ OPSCC Screening Shows Promise

Harvard Med Team Advancing New Sequencing Assay for Screening HPV-Associated Throat Cancer

Head and Neck Cancer Screening Ten Years Before Diagnosis

2023

Most Patients Don’t Realize HPV Causes Throat Cancer, Survey Finds

Making one key connection may increase HPV vax uptake

ctDNA testing- A radical innovation in detecting cancer

Highlights from the cutting edge

2022

Patient Knowledge and Opinions of Human papillomavirus Vaccination for Head and Neck Cancer Prevention

Noninvasive biopsies may be faster and more effective for diagnosing HPV-associated head and neck cancer

Fighting HPV Head and Neck Cancer One Blood Sample at a Time

Advances in Motion

2021

The ABCs of HPV

Liquid Biopsy Provides Accurate, Fast Dx of HPV-Associated Head and Neck Cancer

Blood-Based Diagnosis of Head and Neck Cancer

Liquid biopsy promising for diagnosing head and neck cancer

Blood-Test for HPV-Related Head and Neck Cancer Developed

HPV-associated head and neck cancer blood test shows promise as a test to replace tissue biopsy

Blood Tests Could Replace Tissue Biopsies for HPV-driven Cancers